Â¥
5.90
Apr 30
New Key Statistics Module, Z-Score and F-Score
SZSE:000952 Key Ratios
Market Cap ¥ M | 2,087.78 |
Enterprise Value ¥ M | 2,681.41 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.59 |
Price/Sales | 2.62 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 802.00 |
EPS (TTM) ¥ | -0.41 |
Beneish M-Score | -2.44 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -32.70 |
y-y EBITDA Growth Rate % | -483.10 |
EV-to-EBIT | -27.61 |
EV-to-EBITDA | -27.61 |
PEG | -- |
Shares Outstanding M | 353.86 |
Net Margin (%) | -18.28 |
Operating Margin % | -9.94 |
Pre-tax Margin (%) | -18.69 |
Quick Ratio | 0.85 |
Current Ratio | 1.21 |
ROA % (ttm) | -4.91 |
ROE % (ttm) | -10.38 |
ROIC % (ttm) | -3.61 |
Dividend Yield % | -- |
Altman Z-Score | 1.19 |
SZSE:000952 Number of Guru Trades
SZSE:000952 Volume of Guru Trades
Gurus Latest Trades with SZSE:000952
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:000952 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hubei Guangji Pharmaceutical Co Ltd Insider Transactions
No Available Data